NCT03695822

Impact of Beta-3 Agonist on Psychological Distress and Blood Flow of the Bladder in Women With Overactive Bladder Syndrome

Far Eastern Memorial Hospital

• Status: Withdrawn
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: Far Eastern Memorial Hospital · Academic / Other
• Sex: Female
• Age: 20 Years
• Healthy volunteers: Not accepted

Summary

We will get the impact of mirabegron on psychological distress, urethra and bladder blood flow and c reactive protein.

Detailed description

Background/Purpose: Pharmacologic treatments for female overactive bladder syndrome (OAB) include antimuscarinics and beta-agonist. Similar efficacy has been reported between antimuscarinics and beta-agonist. Antimuscarinics has been found to be beneficial for patients with psychological distress. However, the impact of mirabegron on psychological distress in female OAB remains unknown. In addition, some animal studies found that beta-3 agonist can improve arterial blood flow, bladder ischemia and might improve bladder function; however, there is still lack of human study. Besides, c reactive protein was found to be elevated in female OAB. Nonetheless there is no study mentioning about the impact of mirabegron on c reactive protein. Thus, the aim of this study is to elucidate the impact of mirabegron on psychological distress, bladder blood flow and c reactive protein.

Conditions

• Overactive Bladder Syndrome

Interventions

Type	Name	Description
DRUG	Mirabegron 25mg	The aim of this study is to elucidate the impact of mirabegron on psychological distress, bladder blood flow and c reactive protein.

Timeline

• Start date: 2018-12-24
• Primary completion: 2019-01-21
• Completion: 2019-01-31
• First posted: 2018-10-04
• Last updated: 2019-03-07

Locations

1 site across 1 country: Taiwan